Tomita, Yohei
Cakir, Bertan
Liu, Chi-Hsiu
Fu, Zhongjie
Huang, Shuo
Cho, Steve S.
Britton, William R.
Sun, Ye
Puder, Mark
Hellström, Ann
Talukdar, Saswata
Smith, Lois E. H. http://orcid.org/0000-0003-1013-5737
Funding for this research was provided by:
Manpei Suzuki Diabetes Foundation
Deutsche Forschungsgemeinschaft (CA1940/1-1)
Manton Center for Orphan Disease Research, Boston Children's Hospital
Boston Children's Hospital (Ophthalmology Foundation, OFD/BTREC/CTREC Faculty Career Development Grant, Ophthalmology Foundation, The Vascular Biology Program and the Boston Children’s Hospital Surgery Foundation, 1U54HD090255 (IDDRC))
National Eye Institute (R01EY030140, R01EY029238)
Little Giraffe Foundation (Foundation)
BrightFocus Foundation
The Wallenberg Clinical Scholars
National Institutes of Health (R24EY024868, EY017017, R01EY01717-13S1, EY030904-01)
Mass Lions Eye Research Fund
Article History
Received: 5 December 2019
Accepted: 24 February 2020
First Online: 5 March 2020
Compliance with ethical standards
:
: The authors declare that there is no duality of interest associated with this manuscript. Saswata Talukdar is an employee and stockholder of Merck &Co.
: All animal studies adhered to the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by Institutional Animal Care and Use Committee at Boston Children’s Hospital (ARCH Protocol Number 19-04-3913R).